AbCellera Biologics Inc.
NASDAQAbCellera Biologics heads into the back half of June with a striking internal contradiction: short sellers have been piling in all week, yet options traders are as bullish as they've been in over a year. Short interest is the dominant feature of this setup. At nearly 16% of free float — up 9% on the week and 8% on the month — bearish conviction has been rebuilding steadily since…
Snapshot as of 18 Jun 2026
AbCellera Biologics heads into the back half of June with a striking internal contradiction: short sellers have been piling in all week, yet options traders are as bullish as they've been in over a year. Short interest…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ABCL — free to start on ORTEX.
Sign up for free →Open ABCL on ORTEX